Menu

Share  |  Print  |  Facebook  |  Twitter  |  

Tell Your Senators: Make the Prostate Cancer Diagnosis Process Safer and More Accurate by Supporting the HEARTS Act

Please fill out the form below to tell your Senators to make the prostate cancer diagnosis process safer and more accurate by supporting the HEARTS Act

Recipients

  • Your Senators

Contact

*Required fields
*


 

If you take action and have not already registered, you will receive periodic updates and communications from ZERO - The End of Prostate Cancer.

Protect Patients from the Devastating Impact of Prostate Cancer Misdiagnosis by Supporting the HEARTS Act

Dear [Senator],

As your constituent and someone who has been impacted by prostate cancer, I am writing to ask that you support HR 6886, the Health Equity and Access for Returning Troops and Servicemembers Act of 2018 (HEARTS Act). HR 6886, which was referred to the Senate Finance Committee October 1, 2018, includes an important provision that makes the prostate cancer diagnosis process safer and more accurate.

The current method to diagnose prostate cancer is via needle biopsy of the prostate. Over 800,000 prostate biopsies are performed on men each year. Yet, despite the most rigorous protocols for obtaining and handling specimens, about 2.5% are subject to specimen provenance complications (SPCs), where a specimen from one patient is contaminated by that of another patient.

This issue greatly concerns me because not only do patients receiving false-negatives lose the opportunity to treat their cancer at its earliest possible stage, but patients receiving false-positives an estimated 1.3%, according to peer-reviewed literature -- are erroneously told they have prostate cancer when they do not. This results in extreme emotional and and unnecessary, expensive and invasive procedures, including radical prostatectomy and radiation therapy.

However, we can eliminate misdiagnosis and unnecessary medical care can through the use of DNA Specimen Provenance Assay (DSPA) testing, which simply matches each patient's unique genetic profile to that of the diagnostic tissue read by a pathologist or genetic counselor, in order to rule out the presence of undetected provenance complications prior to treatment. This ensures the proper patient is matched to his specimen.



As your constituent, I urge you to protect patients from the devastating impact of misdiagnosis that can result from SPCs by enacting supporting the HEARTS Act in the form it passed the House and as referred to the Senate Finance Committee, HR 6886. Passing this legislation will provide Medicare reimbursement for the simple and cost-saving DNA test that can eradicate tragic medical errors and ensure that men are not falsely diagnosed with this terrible disease.

Sincerely,
[Your Name]
[Your Address]
[City, State ZIP]
[Your Email]